Astera Labs Inc. (ALAB) financial statements: income statement, balance sheet and cash flow
Astera Labs Inc.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Astera Labs Inc. reported revenue of $852.5M (+115.1% year on year) and net income of $219.1M (+362.7% year on year).
Income statement
Astera Labs Inc. income statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Revenue
$852.5M
$396.3M
Cost of revenue
$207.3M
$93.6M
Gross profit
$645.3M
$302.7M
Research and development
$304.0M
$200.8M
Sales and marketing
$79.8M
$123.7M
General and administrative
$88.1M
$94.3M
Total operating expenses
$471.8M
$418.8M
Operating income (loss)
$173.4M
($116.1M)
Interest income
$44.7M
$34.3M
Income (loss) before income taxes
$218.2M
($81.8M)
Income tax (benefit) provision
($981.0K)
$1.6M
Net income (loss)
$219.1M
($83.4M)
Basic (in dollars per share)
$1.32
-$0.64
Diluted (in dollars per share)
$1.22
-$0.64
Basic (in shares)
166.4M
131.3M
Diluted (in shares)
179.6M
131.3M
Unrealized gain on marketable securities, net of taxes
$3.9M
$167.0K
Total comprehensive income (loss)
$223.0M
($83.3M)
Astera Labs Inc. income statement, quarters
Line item
Jun 30, 2026 · Q2
Mar 31, 2026 · Q1
Sep 30, 2025 · Q3
Jun 30, 2025 · Q2
Revenue
$392.4M
$308.4M
$230.6M
$191.9M
Cost of revenue
$104.8M
$73.2M
$54.8M
$46.4M
Gross profit
$287.6M
$235.1M
$175.8M
$145.6M
Research and development
$135.9M
$125.6M
$78.9M
$66.7M
Sales and marketing
$26.4M
$21.9M
$19.4M
$18.6M
General and administrative
$36.0M
$25.8M
$22.1M
$20.5M
Total operating expenses
$198.3M
$173.3M
$120.4M
$105.8M
Operating income
$89.2M
$61.8M
$55.4M
$39.8M
Interest and other income
$13.6M
—
—
—
Income before income taxes
$102.8M
$73.4M
$66.9M
$50.7M
Income tax benefit
$50.3M
($6.9M)
($24.3M)
($560.0K)
Net income
$153.1M
$80.3M
$91.1M
$51.2M
Basic (in dollars per share)
$0.89
$0.47
$0.54
$0.31
Diluted (in dollars per share)
$0.83
$0.44
$0.50
$0.29
Basic (in shares)
172.4M
170.7M
167.4M
165.4M
Diluted (in shares)
183.3M
181.2M
180.6M
178.1M
Unrealized (loss) gain on marketable securities, net of taxes
($2.6M)
($5.1M)
$1.2M
$846.0K
Total other comprehensive (loss) gain
($2.6M)
($5.1M)
—
$846.0K
Total comprehensive income
$150.5M
$75.2M
$92.3M
$52.1M
Balance sheet
Astera Labs Inc. balance sheet, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Cash and cash equivalents
$167.6M
$79.6M
Marketable securities
$1.0B
$834.8M
Accounts receivable, net
$83.2M
$38.8M
Inventory
$59.0M
$43.2M
Prepaid expenses and other current assets
$31.0M
$16.7M
Total current assets
$1.4B
$1.0B
Property and equipment, net
$92.0M
$35.7M
Other assets
$77.8M
$5.9M
Total assets
$1.5B
$1.1B
Accounts payable
$42.4M
$26.9M
Accrued expenses and other current liabilities
$90.7M
$59.6M
Total current liabilities
$133.0M
$86.5M
Other liabilities
$35.1M
$3.2M
Total liabilities
$168.2M
$89.7M
Common stock, $0.0001 par value; 1,000,000 shares authorized as of December 31, 2025 and 2024, respectively; 170,186 and 162,018 shares issued and outstanding as of December 31, 2025 and 2024, respectively
17.0K
16.0K
Additional paid-in capital
$1.3B
$1.2B
Accumulated other comprehensive income
$4.3M
$426.0K
Retained earnings (accumulated deficit)
$10.3M
($208.8M)
Total stockholders’ equity
$1.4B
$964.8M
Total liabilities and stockholders’ equity
$1.5B
$1.1B
Astera Labs Inc. balance sheet, quarters
Line item
Jun 30, 2026
Mar 31, 2026
Sep 30, 2025
Jun 30, 2025
Cash and cash equivalents
$111.5M
$148.3M
$140.4M
$162.3M
Marketable securities
$1.1B
$1.0B
$994.0M
$902.8M
Accounts receivable, net
$192.5M
$134.8M
$42.9M
$24.3M
Inventory
$113.8M
$60.2M
$51.7M
$58.6M
Prepaid expenses and other current assets
$92.7M
$33.5M
$61.2M
$32.7M
Total current assets
$1.7B
$1.4B
$1.3B
$1.2B
Property and equipment, net
$119.3M
$97.2M
$72.5M
$62.1M
Goodwill
$91.6M
$87.7M
—
—
Other assets
$68.8M
$61.4M
$38.5M
$28.6M
Total assets
$1.9B
$1.7B
$1.4B
$1.3B
Accounts payable
$53.9M
$55.8M
$25.8M
$31.6M
Accrued expenses and other current liabilities
$110.4M
$69.2M
$75.1M
$74.8M
Total current liabilities
$164.3M
$125.0M
$101.0M
$106.4M
Other liabilities
$41.5M
$40.2M
$28.5M
$29.3M
Total liabilities
$205.8M
$165.3M
$129.5M
$135.7M
Common stock, $0.0001 par value; 1,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 173,485 and 170,186 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
17.0K
17.0K
17.0K
17.0K
Additional paid-in capital
$1.5B
$1.4B
$1.3B
$1.3B
Accumulated other comprehensive (loss) income
($3.4M)
($780.0K)
$4.1M
$2.9M
Retained earnings
$243.7M
$90.6M
($34.6M)
($125.8M)
Total stockholders’ equity
$1.7B
$1.5B
$1.3B
$1.1B
Total liabilities and stockholders’ equity
$1.9B
$1.7B
$1.4B
$1.3B
Cash flow statement
Astera Labs Inc. cash flow statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Net income (loss)
$219.1M
($83.4M)
Stock-based compensation
$160.0M
$234.6M
Depreciation and amortization
$6.8M
—
Non-cash operating lease expense
$2.9M
$2.4M
Warrants contra revenue
$5.5M
$1.4M
Accretion of discounts on marketable securities
($7.9M)
($8.3M)
Other
($1.2M)
—
Accounts receivable, net
($44.3M)
($30.5M)
Inventory
($12.9M)
($19.3M)
Prepaid expenses and other assets
($33.8M)
($13.0M)
Accounts payable
$14.2M
$20.9M
Accrued expenses and other liabilities
$15.8M
$31.0M
Operating lease liability
($4.9M)
($2.4M)
Net cash provided by (used in) operating activities
$319.3M
$136.7M
Purchases of property and equipment
($37.5M)
($34.2M)
Purchases of marketable securities
($857.8M)
($930.6M)
Sales and maturities of marketable securities
$683.1M
$208.7M
Payments for business combinations, net of cash acquired
($28.8M)
—
Other investment activities
($500.0K)
($1.4M)
Net cash used in investing activities
($241.5M)
($757.6M)
Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions
$0
$672.2M
Payment of deferred offering costs
$0
($4.8M)
Proceeds from exercises of stock options
$1.8M
$5.5M
Proceeds from employee stock purchase plan
8.0M
4.2M
Tax withholding related to net share settlements of restricted stock units
$0
($20.1M)
Repurchase of common stock upon termination
$0
($1.1M)
Net cash provided by (used in) financing activities
$9.8M
$655.8M
Net increase (decrease) in cash, cash equivalents, and restricted cash
$87.6M
$34.9M
Beginning of the year
$80.0M
$45.1M
End of the year
$167.7M
$80.0M
Astera Labs Inc. cash flow statement, quarters
Line item
Jun 30, 2026 · YTD
Mar 31, 2026 · Q1
Sep 30, 2025 · YTD
Jun 30, 2025 · YTD
Net income
$233.4M
$80.3M
$174.2M
$83.0M
Stock-based compensation
$112.9M
$48.9M
$118.7M
$77.9M
Depreciation and amortization
$7.6M
$3.7M
$4.0M
$2.5M
Non-cash operating lease expense
$2.7M
$1.2M
$2.3M
$1.5M
Warrants contra revenue
$12.3M
$2.1M
$4.0M
$2.1M
Accretion of discounts on marketable securities
($2.2M)
($1.2M)
($6.3M)
($4.5M)
Other, net
($3.0M)
($1.3M)
$231.0K
$734.0K
Accounts receivable, net
($109.5M)
($51.8M)
($4.1M)
$14.5M
Inventory
($53.1M)
$346.0K
($7.1M)
($14.6M)
Prepaid expenses and other assets
($41.4M)
$13.9M
($56.8M)
($18.5M)
Accounts payable
$2.8M
($699.0K)
($1.1M)
$4.6M
Accrued expenses and other liabilities
($357.0K)
($20.8M)
($624.0K)
($1.6M)
Net cash provided by operating activities
$162.3M
$74.6M
$224.0M
$145.9M
Purchases of property and equipment
($28.1M)
($7.6M)
($18.9M)
($6.6M)
Purchases of marketable securities
($359.7M)
($156.6M)
($664.4M)
($404.7M)
Sales and maturities of marketable securities
$233.9M
$137.8M
$515.1M
$343.6M
Payments for business combinations, net of cash acquired
($69.2M)
($65.0M)
—
—
Other investing activities
($2.5M)
($2.5M)
($500.0K)
—
Net cash used in investing activities
($225.6M)
($94.0M)
($168.7M)
($67.6M)
Proceeds from exercises of stock options
$836.0K
$82.0K
$1.7M
$778.0K
Proceeds from employee stock purchase plan
6.3M
—
4.3M
4.3M
Net cash provided by financing activities
$7.1M
$82.0K
$6.1M
$5.1M
Net (decrease) increase in cash, cash equivalents, and restricted cash